The Enhabit Inc (EHAB) share price is expected to increase by 19.08% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered EHAB. Price targets range from $8 at the low end to $11 at the high end. The current analyst consensus for EHAB is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assigned EHAB 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Enhabit Inc to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on EHAB. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of EHAB.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Joanna Gajuk B of A Securities | Underperform | $8 | Maintains | Jun 27, 2024 |
Whit Mayo Leerink Partners | Market Perform | $8.5 | Upgrade | May 14, 2024 |
Brian Tanquilut Jefferies | Hold | $8.75 | Downgrade | May 9, 2024 |
Ryan Langston TD Cowen | Market Perform | $11 | Maintains | Mar 11, 2024 |
A.J. Rice UBS | Neutral | $9.5 | Upgrade | Mar 7, 2024 |
Michael Wiederhorn Oppenheimer | Perform | Maintains | Mar 7, 2024 | |
Brian Tanquilut Jefferies | Buy | $14 | Maintains | Mar 6, 2024 |
Ryan Langston TD Cowen | Market Perform | $12 | Initiates | Dec 12, 2023 |
Jonathan Yong Credit Suisse | Neutral | $12 | Maintains | Aug 11, 2023 |
Jamie Perse Goldman Sachs | Neutral | $13 | Maintains | Jul 17, 2023 |
Jamie Perse Goldman Sachs | Neutral | $15 | Initiates | Mar 16, 2023 |
Jason Cassorla Citigroup | Neutral | $18 | Maintains | Feb 17, 2023 |
Jonathan Yong Credit Suisse | Neutral | $15 | Reiterates | Feb 16, 2023 |
Larry Solow CJS Securities | Market Perform | $18 | Initiates | Dec 13, 2022 |
Andrew Mok UBS | Sell | $12 | Initiates | Dec 8, 2022 |
Tao Qiu Stifel | Buy | $17 | Initiates | Dec 6, 2022 |
Jonathan Yong Credit Suisse | Neutral | $15 | Maintains | Nov 4, 2022 |
Michael Wiederhorn Oppenheimer | Perform | Initiates | Oct 14, 2022 | |
Brian Tanquilut Jefferies | Buy | $20 | Initiates | Aug 30, 2022 |
A.J. Rice Credit Suisse | Neutral | $19 | Initiates | Aug 25, 2022 |
When did it IPO
2022
Staff Count
10,800
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T.
Market Cap
$383.7M
In 2023, EHAB generated $1.05B in revenue, which was a decrease of -2.32% from the previous year. This can be seen as a signal that EHAB's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Enhabit, Inc. (NYSE: EHAB) has been recognized by the Institute for Healthcare Improvement as an Age-Friendly Health Systems Participant, focusing on essential care elements for older patients.
Why It Matters - Enhabit's recognition as an Age-Friendly Health Systems Participant enhances its reputation, potentially attracting more clients and improving financial performance in the growing senior care market.
Summary - Enhabit, Inc. (NYSE: EHAB) will report Q3 results on Nov. 6, 2024, and hold a conference call on Nov. 7 at 10 a.m. EST. Participation details include a toll-free number and conference ID.
Why It Matters - Enhabit's upcoming quarterly results and conference call could influence stock performance and investor sentiment, providing insights into the company's financial health and growth prospects.
Summary - On September 30, 2024, Vanguard Group reduced its holdings in Enhabit Inc (EHAB) by 626,911 shares, bringing its total stake to 2,976,480 shares.
Why It Matters - Vanguard's reduction in Enhabit shares signals potential concerns about the company's outlook, possibly affecting investor confidence and stock performance.
Summary - S&P Dow Jones Indices will implement changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices on September 23, 2024, ahead of the quarterly rebalance.
Why It Matters - Changes to the S&P indices can impact stock prices and investor sentiment, affecting portfolio allocations and potentially influencing market trends.
Summary - Enhabit, Inc. (NYSE: EHAB) will participate in the Jefferies Healthcare Services Summit on Aug. 28 and the Wells Fargo Healthcare Conference, featuring CEO Barb Jacobsmeyer and CFO Crissy Carlisle.
Why It Matters - Enhabit's participation in notable investor conferences highlights its commitment to transparency and growth, potentially influencing investor confidence and stock performance.
Summary - Enhabit, Inc. (NYSE: EHAB) held its Q2 2024 earnings conference call on August 7, 2024, featuring CEO Barb Jacobsmeyer and CFO Crissy Carlisle.
Why It Matters - The earnings call provides insights into Enhabit's financial performance and future outlook, influencing investor sentiment and stock valuation.